Basem Ahmed

Professor
Basem
Ahmed

Associate professor
Department of Virology, Faculty of Veterinary Medicine, Cairo University
LinkedIn 
View profile
Biography

Dr. Basem Ahmed graduated from the Faculty of Veterinary Medicine at Cairo University in 2007. He earned his master's degree in 2012 and his PhD in 2016, both in virology, focusing on influenza virus vaccines. In 2019, he trained in Varicellovirus equidalpha1 genome manipulation at the Institute of Virology, Free University of Berlin, Germany. Following his PhD, Dr. Ahmed led research in the virology graduate lab, participated in five research grants (two as principal investigator), mentored numerous master's and PhD students, and published over 30 peer-reviewed articles on various virology topics. He has advised two local vaccine manufacturers and contributed to the development of several poultry vaccines currently available in the Egyptian market. Currently, Dr. Ahmed is the chairman of the Department of Virology at Cairo University's Faculty of Veterinary Medicine, a board member of the Egyptian Society of Virology, and the Editor-in-Chief of the Journal of Virological Sciences. His primary research interests include tracking and understanding the evolution of animal viruses, improving diagnostics and vaccines for animal viruses, and promoting One Health initiatives.

Research interests

Conventional viral vaccine, molecular biology based vaccines, vaccine production, vaccine evaluation, viral evolution studies, and virus diagnosis.

Projects you're working on

Development and evaluation of trivalent vaccine against H5, H9, and ND for poultry using ISA71 oil adjuvant (finished/ published)

Development and evaluation of Multi-IB and velogenic ND vaccine using ISA70 oil adjuvant (finished/ published)

Former R&D manager at Vaccine Valley (veterinary vaccine manufacturer in Egypt)

Current Chief Technical Officer for poultry vaccine (EgyVac the sole  agent of BiotestLab.UA in Egypt)

Discipline
Bio-manufacturing Bioinformatics Challenge study design Clinical trials – efficacy Clinical trials – safety Commercialisation Ethics Formulation technology Immunology – innate Molecular biology QC test development Safety evaluation Virology
Host species
Buffalo Camels Cattle Dogs Fish Horses Poultry Small ruminants
Pathogen
BacteriaClostridia BacteriaE. coli Viruses VirusesAdenovirus VirusesCapripoxvirus VirusesChicken anaemia virus VirusesCoronavirus VirusesFoot-and-mouth disease virus VirusesHerpesvirus VirusesInfectious bursal disease virus VirusesInfectious pancreatic necrosis virus VirusesInfectious salmon anaemia virus VirusesInfluenza virus VirusesMareks disease virus VirusesNewcastle disease virus VirusesParamyxoviruses VirusesParvovirus VirusesPeste des petits ruminants virus VirusesPiscine novirhabdovirus VirusesPoxviruses VirusesRabies virus VirusesRespiratory syncytial virus VirusesRetroviruses VirusesRift Valley fever virus
Stage of vaccine development
Adjuvants Antigen discovery and immunogen design Clinical trials Commercialisation Correlates of protection – immunomonitoring Field trials Marketing Pre-clinical trials Vaccine delivery